(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 9.76%1.11B | 19.62%748.77M | 16.68%320.53M | 2.42%1.41B | -2.16%1.02B | -1.83%625.98M | -1.80%274.72M | 16.03%1.37B | 21.78%1.04B | 21.10%637.68M |
Operating income | 9.76%1.11B | 19.62%748.77M | 16.68%320.53M | 2.42%1.41B | -2.16%1.02B | -1.83%625.98M | -1.80%274.72M | 16.03%1.37B | 21.78%1.04B | 21.10%637.68M |
Operating expenses | -4.96%-941.34M | -14.37%-624.56M | -18.24%-274.83M | -0.32%-1.19B | 0.26%-896.9M | 1.27%-546.09M | 5.22%-232.44M | -12.65%-1.19B | -20.07%-899.28M | -22.04%-553.12M |
Gross profit | 45.98%173.5M | 55.47%124.21M | 8.09%45.7M | 15.84%215.22M | -14.43%118.85M | -5.51%79.89M | 22.49%42.28M | 43.59%185.8M | 34.15%138.89M | 15.30%84.55M |
Selling expenses | -27.18%-34.55M | -31.06%-23.47M | -27.32%-10.49M | -44.70%-46.22M | -12.13%-27.17M | -13.03%-17.91M | 16.99%-8.24M | 6.16%-31.94M | 30.72%-24.23M | -5.26%-15.84M |
Administrative expenses | -17.86%-83.73M | -19.82%-57.29M | -4.15%-25.89M | -18.32%-120.48M | -9.17%-71.04M | -24.73%-47.81M | -21.03%-24.85M | -7.03%-101.82M | -15.29%-65.08M | 3.96%-38.33M |
Research and development expenses | 7.52%-45.32M | -6.56%-30.02M | 5.07%-14.17M | -39.45%-66.45M | -50.52%-49M | -30.34%-28.17M | -90.64%-14.93M | -79.56%-47.65M | -115.16%-32.55M | -115.81%-21.62M |
Profit from asset sales | -74.88%11.86K | ---- | ---- | -61.92%123.48K | --47.21K | --55.42K | ---- | 64.35%324.29K | ---- | ---- |
Revaluation surplus | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---30.68K | ---5.95K |
-Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---30.68K | ---5.95K |
Impairment and provision | 17.75%-17.45M | 10.50%-14.19M | 116.99%1.33M | -135.14%-37.47M | -352.09%-21.21M | -188.51%-15.85M | -10,952.76%-7.85M | 25.60%-15.94M | 52.28%-4.69M | 46.38%-5.49M |
-Other impairment is provision | 17.75%-17.45M | 10.50%-14.19M | 116.99%1.33M | -135.14%-37.47M | -352.09%-21.21M | -188.51%-15.85M | -10,952.76%-7.85M | 25.60%-15.94M | 52.28%-4.69M | 46.38%-5.49M |
Special items of operating profit | 124.56%24.02M | 240.31%20.87M | 153.36%8.65M | -44.68%22.49M | -46.98%10.7M | -60.13%6.13M | -36.87%3.41M | 39.18%40.66M | 39.91%20.18M | 36.27%15.38M |
Operating profit | 122.14%9.86M | 157.54%15.47M | 131.53%3.7M | -285.61%-40.69M | -265.09%-44.56M | -279.12%-26.88M | -8,148.39%-11.75M | 192.02%21.92M | 1,161.21%26.99M | 114.37%15.01M |
Financing cost | 39.48%-7.05M | 24.36%-4.76M | 40.72%-2.86M | -47.92%-13.56M | -240.07%-11.65M | -113.92%-6.29M | -89.04%-4.83M | 28.48%-9.17M | 60.41%-3.43M | 52.50%-2.94M |
Special items of earning before tax | -183.23%-515.29K | -128.74%-283.34K | -164.03%-379.91K | -90.29%876.18K | -80.72%619.1K | 386.76%985.96K | 4.32%593.36K | 2,157.26%9.02M | 326.38%3.21M | -181.96%-343.83K |
Earning before tax | 104.13%2.3M | 132.40%10.43M | 102.89%462K | -345.08%-53.37M | -307.63%-55.59M | -374.55%-32.18M | -768.80%-15.98M | 158.74%21.78M | 356.38%26.78M | 853.01%11.72M |
Tax | -123.82%-10.71M | -3.44%-6.8M | -10.17%-3.8M | -185.93%-22.88M | 11.38%-4.79M | -116.66%-6.57M | -214.91%-3.45M | -92.40%-8M | -84.77%-5.4M | -64.14%-3.03M |
After-tax profit from continuing operations | 86.06%-8.42M | 109.35%3.63M | 82.82%-3.34M | -653.52%-76.25M | -382.49%-60.38M | -546.13%-38.76M | -562.11%-19.43M | 133.41%13.78M | 259.90%21.37M | 1,504.10%8.69M |
Earning after tax | 86.06%-8.42M | 109.35%3.63M | 82.82%-3.34M | -653.52%-76.25M | -382.49%-60.38M | -546.13%-38.76M | -562.11%-19.43M | 133.41%13.78M | 259.90%21.37M | 1,504.10%8.69M |
Minority profit | 172.41%7.65M | 177.20%7M | 186.62%3.19M | -441.43%-24.58M | -1,715.33%-10.57M | -380.08%-9.07M | -118.24%-3.68M | 74.72%-4.54M | 110.29%654.2K | -371.97%-1.89M |
Profit attributable to shareholders | 67.75%-16.07M | 88.63%-3.37M | 58.60%-6.52M | -382.14%-51.68M | -340.40%-49.81M | -380.71%-29.69M | -1,160.35%-15.76M | 178.67%18.32M | 395.53%20.72M | 905.37%10.58M |
Basic earnings per share | 66.67%-0.03 | 80.00%-0.01 | 66.67%-0.01 | -350.00%-0.1 | -325.00%-0.09 | -350.00%-0.05 | -200.00%-0.03 | 180.00%0.04 | 500.00%0.04 | 300.00%0.02 |
Diluted earnings per share | 66.67%-0.03 | 80.00%-0.01 | 66.67%-0.01 | -350.00%-0.1 | -400.00%-0.09 | -350.00%-0.05 | -200.00%-0.03 | 180.00%0.04 | 400.00%0.03 | 300.00%0.02 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data